Replimune - 53 Year Dividend History | REPL
Historical dividend payout and yield for Replimune (REPL) since 1971. The current TTM dividend payout for Replimune (REPL) as of December 20, 2024 is $0.00. The current dividend yield for Replimune as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.859B |
$0.000B |
|
Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
